Recruiting studies: Attr Amyloidosis With Cardiomyopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase N/A · 1 location(s) · Yale University · NCT07398950 FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169 PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
NA · 1 location(s) · Richmond Research Institute · NCT05098665 CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in Peop
Phase 3 · 292 location(s) · Novo Nordisk A/S · NCT07207811 A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT I
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07448623 TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3 · 240 location(s) · Alnylam Pharmaceuticals · NCT07052903 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · 132 location(s) · Intellia Therapeutics · NCT06128629 A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability,
Phase 1/Phase 2 · 3 location(s) · YolTech Therapeutics Co., Ltd · NCT06539208 Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients Wit
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT07196839 Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Phase 1/Phase 2 · 1 location(s) · Steen Hvitfeldt Poulsen · NCT06318260 US Benchmarking Clinical Study
Phase N/A · 3 location(s) · eMyosound SAS · NCT07215715 A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopa
Phase N/A · 1 location(s) · Bayer · NCT07235462 A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloid
Phase 4 · 20 location(s) · Bayer · NCT07298044 DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Phase N/A · 4 location(s) · Alnylam Pharmaceuticals · NCT07358078 Hungarian National Systemic Amyloidosis Registry
Phase N/A · 12 location(s) · Semmelweis University · NCT07689331 An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Progra
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06907186 A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, a
Phase N/A · 8 location(s) · Medical University of Vienna · NCT06836011 Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Phase N/A · 4 location(s) · Intellia Therapeutics · NCT05697861

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.